AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2024
Dec 17, 2024
32870_dirs_2024-12-17_c768767e-8ad2-49b5-a3e2-9f1e83e18ff3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2024-12-15
Reporting Person: Lowry Simon C (SVP, R&D, CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-15 | Common Stock | A | 29482 | — | Acquired | 29482 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-15 | Employee Stock Option (Right to buy) | $8.48 | A | 40499 | Acquired | 2031-12-14 | Common Stock (40499) | Direct |
Footnotes
F1: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
F2: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.